Buy the GCP R3 course & get a FREE eBook— your complete ICH-GCP R3 reference guide. Book Now →

  • Preclinical & Laboratory Foundations Learning Path
  • Phase I – First-in-Human Trials Learning Path
  • Phase II & III – Efficacy & Pivotal Trials Learning Path
  • Clinical Trials Foundation PathNew
  • Regulatory Submission & Approval

About

Introduction to Advanced Therapy Medicinal Products (ATMPs) provides a foundational understanding of innovative therapies based on genes, cells, and tissues. The course explains key ATMP concepts, regulatory requirements, manufacturing principles, and quality considerations essential for developing safe and effective advanced therapies.
This Introduction to ATMP Training Course covers ATMP classifications, EU regulatory framework, cell and gene therapy principles, GMP requirements, starting and ancillary materials, chain of identity, aseptic processing, quality risk management, potency, comparability, and regulatory expectations. Upon successful completion, learners gain essential knowledge of ATMP development, manufacturing, and quality practices.

Who Should Enrol?

  • Pharmaceutical and biotechnology professionals
  • Cell and gene therapy researchers
  • Quality Assurance and Quality Control professionals
  • Manufacturing and process development teams
  • Regulatory affairs professionals
  • Clinical research and healthcare professionals
  • Anyone seeking knowledge of advanced therapy medicinal products
📢 Every purchase also includes our FREE companion Introduction to Advanced Therapy Medicinal Products eBook, designed to help you apply principles in real-world clinical trial settings.

What you will learn

Understand the fundamentals of Advanced Therapy Medicinal Products (ATMPs), including gene therapies, cell therapies, and tissue-engineered products.

Learn ATMP classification, regulatory frameworks, GMP principles, and key quality requirements for advanced therapies.

Develop knowledge of starting materials, ancillary materials, traceability, aseptic processing, potency, and comparability concepts.

Gain understanding of risk management, regulatory expectations, and quality considerations to support safe and effective ATMP development.

Course Syllabus

  1. What ATMPs are and why they are different from conventional medicines
  2. The four classes of ATMP
  3. Autologous versus allogeneic products
  4. How ATMPs differ from conventional medicines
  5. The ATMP landscape: modalities and examples
  6. The manufacturing challenge and the road ahead

  1. The EU framework: Regulation (EC) No 1394/2007 and the Committee for Advanced Therapies
  2. EU routes to market: MA, hospital exemption and PRIME
  3. The US framework: PHS Act, FDA and CBER
  4. US human cells and tissues and 21 CFR 1271
  5. Expedited and access pathways
  6. Comparing the EU and US frameworks

  1. The EU Part IV GMP guidelines
  2. The risk-based approach to ATMP GMP
  3. The US GMP framework: cGMP, biologics and CGTP
  4. The Pharmaceutical Quality System for ATMPs
  5. GMP fundamentals: people, documents and data
  6. Comparing EU and US GMP and getting started

  1. Facility design and layout for ATMPs
  2. Cleanroom grades and classification
  3. Segregation, containment and GMO handling
  4. Closed and functionally closed systems
  5. Critical utilities and their control
  6. Environmental monitoring for ATMP campaigns

  1. Applying Annex 1 and the CCS to ATMPs
  2. Closed and functionally closed aseptic processing
  3. Aseptic technique and interventions
  4. Aseptic process simulation for ATMPs
  5. Sterility testing and rapid methods
  6. The short-shelf-life problem and release

  1. Starting materials: cells, tissues and vectors
  2. Donor eligibility and sourcing
  3. Raw and ancillary materials qualification
  4. Single-use systems and supplier qualification
  5. Traceability and coding
  6. Managing the incoming supply chain

  1. The manufacturing process and batch definition
  2. In-process control and process validation
  3. Quality control: identity, purity, potency and safety
  4. Comparability across changes
  5. Batch release in the EU and US
  6. Deviations, OOS and short-shelf-life release

  1. The quality system in operation
  2. Chain of identity and custody
  3. Cold chain and logistics
  4. Pharmacovigilance and long-term follow-up
  5. Preparing for EU and FDA inspection
  6. Preparing for EU and FDA inspection

  1. 📘 Bonus: Introduction to Advanced Therapy Medicinal Products eBook (Free with purchase)

Course Benefits

Benefits ebook icon
eBook

Access the course content in eBook format, which can be downloaded and read on your device.

Benefits cpd_points icon
CPD Points

Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.

Benefits certification icon
Certification

Receive a personal certificate to show your subject knowledge on course completion.

Benefits affordable icon
Affordable

You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.

Benefits flexible icon
Flexibility

The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.

Benefits up_to_date icon
Keep Up to Date

You will stay current with the EU framework for ATMPs (Regulation (EC) No 1394/2007 and the EudraLex Volume 4 Part IV GMP guidelines) and the US framework (Public Health Service Act section 351, 21 CFR Parts 210/211 and 1271, and FDA/CBER expectations), together with the application of the revised EU GMP Annex 1 to aseptic processing and sterility assurance for cell and gene therapies.

Benefits industry_experts icon
Learn from Industry Experts

This course was developed by cell- and gene-therapy and GMP specialists with practical experience of ATMP process development, aseptic manufacturing, regulatory submission and inspection across the EU and US. Each module ties the requirements to real manufacturing decisions and inspection expectations.


Our Certified Customers

novartis
NHS
takeda
roche
dhl

Learner Rating & Reviews

4.7
Average Rating
536 global ratings
87.0%
5.0%
3.0%
3.0%
2.0%
RC

Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP course...

SM

I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...